SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-19-000093
Filing Date
2019-08-06
Accepted
2019-08-06 16:16:23
Documents
55
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvncq21910q.htm   iXBRL 10-Q 1452345
2 EXHIBIT 31.1 rvnc-q219exhibit311.htm EX-31.1 12991
3 EXHIBIT 31.2 rvnc-q219exhibit312.htm EX-31.2 12881
4 EXHIBIT 32.1 rvnc-q219exhibit321.htm EX-32.1 7643
5 EXHIBIT 32.2 rvnc-q219exhibit322.htm EX-32.2 7662
  Complete submission text file 0001479290-19-000093.txt   5219634

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20190630.xsd EX-101.SCH 33877
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20190630_cal.xml EX-101.CAL 62576
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20190630_def.xml EX-101.DEF 146268
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20190630_lab.xml EX-101.LAB 485142
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20190630_pre.xml EX-101.PRE 265863
11 EXTRACTED XBRL INSTANCE DOCUMENT rvncq21910q_htm.xml XML 736557
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 191002264
SIC: 2834 Pharmaceutical Preparations